Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry

European Journal of Endocrinology

Volumn 165, Issue 6, 2011, Pages 917-924

  Giton, Frank ^a,b   Fiet, Jean ^b   Cornu, Jean Nicolas ^c   Cussenot, Olivier ^c   Bélanger, Alain ^d   Urien, Saík ^e   Oliva, Alejandro ^f   Blanchet, Pascal ^g,h   Multigner, Luc ^h  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL TENON   (France)

^d LAVAL UNIVERSITY   (Canada)

^e Tarnier Hospital   (France)

^f HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^g Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^h CHU Pointe ̀a Pitre ^*  (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE SULFATE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AFRICAN CARIBBEAN; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPEAN; HORMONE BLOOD LEVEL; HUMAN; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEASON; SEX HORMONE DETERMINATION; SMOKING; WAIST HIP RATIO;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; ANDROSTENEDIONE; BIOLOGICAL MARKERS; CARIBBEAN REGION; ESTRONE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; TESTOSTERONE;

EID: 81555195440     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0551     Document Type: Article

References (34)

1. Jolly S, Vittinghoff E, Chattopadhyay A & Bibbins-Domingo K. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. American Journal of Medicine 2010 123 811-818. (doi:10.1016/j.amjmed. 2010.04.020)
2. Araujo AB, Travison TG, Harris SS, Holick MF, Turner AK & McKinlay JB. Race/ethnic differences in bone mineral density in men. Osteoporosis International 2007 18 943-953. (doi:10.1007/ s00198-006-0321-9)
3. Tracy JK, Meyer WA, Grigoryan M, Fan B, Flores RH, Genant HK, Resnik C & Hochberg MC. Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men's Osteoporosis Study. Osteoporosis International 2006 17 99-104. (doi:10.1007/ s00198-005-1919-z)
4. Hsing AW, Tsao L & Devesa SS. International trends and patterns of prostate cancer incidence and mortality. International Journal of Cancer 2000 85 60-67. (doi:10.1002/(SICI)1097-0215 (20000101)85:1〈60::AID-IJC11〉3.0. CO;2-B)
5. Ross R, Bernstein L, Judd H, Hanisch R, Pike M & Henderson B. Serum testosterone levels in healthy young black and white men. Journal of the National Cancer Institute 1986 76 45-48. (Pubitemid 16156102)
6. Ellis L & Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 1992 57 72-75. (doi:10.1016/0039-128X(92)90032-5)
7. Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM & Paffenbarger RS. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiology, Biomarkers & Prevention 1995 4 735-741.
8. Ettinger B, Sidney S, Cummings SR, Libanati C, Bikle DD, Tekawa IS, Tolan K & Steiger P. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. Journal of Clinical Endocrinology and Metabolism 1997 82 429-434. (doi:10.1210/jc.82.2.429)
9. Platz EA, Rimm EB, Willett WC, Kantoff PW & Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. Journal of the National Cancer Institute 2000 92 2009-2017. (doi:10.1093/jnci/ 92.24.2009)
10. Asbell SO, Rajmane KC, Montesano AT, Zeitzer KL, Asbell MD & Vijayakumar S. Prostate-specific antigen and androgens in African- American and white normal subjects and prostate cancer patients. Journal of the National Medical Association 2000 92 445-449.
11. Winters SJ, Brufsky A,Weissfeld J, Trump DL, Dyky MA & Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 2001 50 1242-1247. (doi:10.1053/meta.2001.26714)
12. Ukkola O, Gagnon J, Rankinen T, Thompson PA, Hong Y, Leon AS, Rao DC, Skinner JS, Wilmore JH & Bouchard C. Age, body mass index, race and other determinants of steroid hormone variability: the Heritage Family Study. European Journal of Endocrinology 2001 145 1-9. (doi:10.1530/eje.0.1450001)
13. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C & Liu K. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiology, Biomarkers & Prevention 2002 11 1041-1047. (Pubitemid 35192655)
14. Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ & Whittemore AS. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African- Americans and Caucasians (United States). Cancer Causes & Control 2006 17 1237-1244. (doi:10.1007/s10552-006- 0052-4)
15. Litman HJ, Bhasin S, Link CL, Araujo AB & McKinlay JB. Serum androgen levels in black, Hispanic, and white men. Journal of Clinical Endocrinology and Metabolism 2006 91 4326-4334. (doi:10.1210/jc.2006-0037)
16. Rohrmann S, Nelson WG, Rifai N, Brown TR, Dobs A, Kanarek N, Yager JD & Platz EA. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. Journal of Clinical Endocrinology and Metabolism 2007 92 2519-2525. (doi:10.1210/jc. 2007-0028)
17. Orwoll ES, Nielson CM, Labrie F, Barrett-Connor E, Cauley JA, Cummings SR, Ensrud K, Karlsson M, Lau E, Leung PC, Lunggren O, Mellström D, Patrick AL, Stefanick ML, Nakamura K, Yoshimura N, Zmuda J, Vandenput L & Ohlsson C. Osteoporotic Fractures in Men (MrOS) Research Group. Evidence for geographical and racial variation in serum sex steroid levels in older men. Journal of Clinical Endocrinology and Metabolism 2010 95 151-160. (doi:10.1210/jc.2009-2435)
18. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 2007 92 405-413. (doi:10.1210/ jc.2006-1864)
19. Multigner L, Ndong JR, Giusti A, Romana M, Delacroix-Maillard H, Cordier S, Jégou B, Thome JP & Blanchet P. Chlordecone exposure and risk of prostate cancer. Journal of Clinical Oncology 2010 28 3457-3462. (doi:10.1200/JCO.2009.27.2153)
20. Giton F, Urien S, Born C, Tichet J, Guéchot J, Callebert J, Bronsard F, Raynaud JP & Fiet J. Determination of bioavailable testosterone (non sex hormone binding globulin (SHBG)-bound testosterone) in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG. Clinical Chemistry 2007 53 2160-2168. (doi:10.1373/clinchem.2007.087312)
21. Morgan TO, Jacobsen SJ, McCarthyWF, Jacobson DJ, McLeod DG & Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. New England Journal of Medicine 1996 335 304-310. (doi:10.1056/NEJM199608013350502)
22. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C & Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. Journal of Steroid Biochemistry and Molecular Biology 2006 99 182-188. (doi:10. 1016/j.jsbmb.2006.02.004)
23. Giton F, Caron P, Bérubé R, Bélanger A, Barbier O & Fiet J. Plasma estrone sulfate assay in men: comparison of radioimmunoassay, mass spectrometry coupled to gas chromatography (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Clinica Chimica Acta 2010 411 1208-1213. (doi:10.1016/j.cca. 2010.04.022)
24. Manni A, Pardridge WM, Cefalu W, Nisula BC, Bardin CW, Santner SJ & Santen RJ. Bioavailability of albumin-bound testosterone. Journal of Clinical Endocrinology and Metabolism 1985 61 705-710. (doi:10.1210/jcem-61-4-705)
25. Morley JE, Patrick P & Perry HM III. Evaluation of assays available to measure free testosterone. Metabolism 2002 51 554-559. (doi:10.1053/meta. 2002.31975)
26. Dunn JF, Nisula BC & Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 1981 53 58-68. (doi:10.1210/jcem-53-1-58)
27. Miyamoto H, Yeh S, Lardy H, Messing E & Chang C. Δ5- Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. PNAS 1998 95 11083-11088. (doi:10.1073/pnas.95.19.11083)
28. Longcope C, Kato T & Horton R. Conversion of blood androgens to estrogens in normal adult men and women. Journal of Clinical Investigation 1969 48 2191-2201. (doi:10.1172/JCI106185)
29. Hsing AW. Hormones and prostate cancer: what's next? Epidemiologic Reviews 2001 23 42-58. (Pubitemid 32906613)
30. Eriksson AL, Lorentzon M, Vandenput L, Labrie F, Lindersson M, Syvänen AC, Orwoll ES, Cummings SR, Zmuda JM, Ljunggren O, Karlsson MK, Mellström D & Ohlsson C. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. Journal of Clinical Endocrinology and Metabolism 2009 94 1033-1041. (doi:10.1210/jc.2008-1283)
31. Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A & Cancel-Tassin G. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. Journal of Clinical Oncology 2007 25 3596-3602. (doi:10.1200/JCO. 2007.11.0908)
32. Beuten J, Gelfond JA, Franke JL,Weldon KS, Crandall AC, Johnson- Pais TL, Thompson IM & Leach RJ. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2009 18 1869-1880. (doi:10.1158/ 1055-9965.EPI-09-0076)
33. Ntais C, Polycarpou A & Tsatsoulis A. Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgenrelated genes. European Journal of Endocrinology 2003 149 469-477. (doi:10.1530/eje.0.1490469)
34. Salam MT, Ursin G, Skinner EC, Dessissa T & Reichardt JK. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer. Urologic Oncology 2005 23 246-253. (Pubitemid 40961936)